Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval

Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.

The biggest challenge for Differin Gel's launch as the first OTC acne ingredient approved in the US in 20 years isn't other acne treatment formulations but rather their entrenched presence in e-commerce, social media and infomercials.

Galderma Laboratories L.P.'s pending launch of the adapalene gel 0.1% product will come with three-year market exclusivity allowed for OTC...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America